The Science Behind Flexbeam
Targeted Red and Near-Infrared Light Therapy
FlexBeam is a wearable device that employs red (625–635nm) and near-infrared (810–845nm) light wavelengths to deliver photobiomodulation (PBM) therapy directly to the body. This approach stimulates cellular processes, promoting healing and recovery.
Mitochondrial Activation
The light wavelengths used by FlexBeam penetrate the skin to reach mitochondria, the energy centers of cells. This stimulation enhances the production of adenosine triphosphate (ATP), boosting cellular energy and facilitating repair processes.
Enhanced Blood Flow
PBM therapy increases nitric oxide production, leading to vasodilation and improved blood circulation. This aids in delivering oxygen and nutrients to tissues, accelerating healing.
Reduced Inflammation and Pain
By modulating inflammatory pathways and decreasing oxidative stress, FlexBeam helps alleviate pain and inflammation in targeted areas.
Accelerated Recovery
Clinical studies have shown that FlexBeam users experience up to 33% faster recovery from muscle strains and injuries.
Improved Strength & Performance
In-house research indicates a 40% improvement in strength performance among users, highlighting its potential in athletic enhancement.
Pain Reduction
Users report a 75% decrease in musculoskeletal pain, emphasizing its efficacy in pain management.
Enhanced Sleep Quality
FlexBeam usage has been associated with a 30% improvement in deep sleep, contributing to overall well-being.